CD Genomics Launches Advanced Whole Exome Sequencing Service, Empowering Genetic Research

July 23, 2023

CD Genomics, a renowned provider of genomics services, is proud to unveil its cutting-edge Whole Exome Sequencing (WES) service. This offering provides researchers and clinicians with a powerful tool to investigate the exome, shedding light on the intricacies of the human genome and propelling our understanding of genetic diseases.


In the era of precision medicine, comprehensive and precise genetic information plays a pivotal role. CD Genomics' Whole Exome Sequencing service is meticulously designed to provide researchers with an all-encompassing view of the coding regions of the genome. Doing so enables the identification and analysis of genetic variants potentially associated with disease development, progression, and treatment response.


Key Advantages of CD Genomics’ Whole Exome Sequencing Service:

Unparalleled Precision and Depth: Employs state-of-the-art next-generation sequencing (NGS) technologies and stringent quality control measures, ensuring highly accurate and reliable sequencing results. Their team of seasoned experts leverages advanced bioinformatics analysis to generate comprehensive and comprehensible data.


Comprehensive Coverage: WES service encompasses all exonic regions, capturing the protein-coding genes that account for the majority of known disease-related mutations. This broad coverage facilitates the exploration of various genetic variations, including single nucleotide variants (SNVs), insertions/deletions (indels), and structural variants (SVs).


Tailored Solutions: CD Genomics recognizes the unique nature of each research project. Their team of dedicated scientists collaborates closely with clients to customize the sequencing strategy and analysis pipeline, ensuring optimal efficiency and data relevance for specific research goals.


Swift Turnaround Time: Time is of the essence in time-sensitive research projects. CD Genomics streamlines its workflow and project management processes to deliver high-quality sequencing data and comprehensive analysis reports within a short turnaround time.


Confidentiality and Data Security: CD Genomics places utmost importance on maintaining confidentiality and data security throughout the sequencing process. Stringent measures are implemented to safeguard the privacy and integrity of clients' valuable data, fostering trust and peace of mind.


CD Genomics remains committed to advancing genomics research and precision medicine by leveraging cutting-edge technologies and providing exceptional customer service. Through their Whole Exome Sequencing service, researchers and clinicians gain the means to unravel the mysteries of the exome, facilitating groundbreaking discoveries and personalized therapeutic interventions.


The senior expert at CD Genomics, expressed their enthusiasm for the WES service, stating, "Our Whole Exome Sequencing service represents a significant leap forward in genomics research. By focusing on the exome, we can uncover key insights into the genetic basis of diseases and enable personalized medicine approaches. The combination of our advanced sequencing technologies and robust bioinformatics analysis ensures that researchers and clinicians receive high-quality data that is crucial for their studies."


About CD Genomics

CD Genomics is a leading global provider of genomics solutions, dedicated to delivering high-quality, efficient, and accurate genomics services to researchers worldwide. The company's team of experienced scientists and technicians, combined with advanced technology platforms and comprehensive data analysis capabilities, enables them to offer a wide range of genomics research solutions. CD Genomics' products and services find applications in various fields, including life science research, drug discovery, clinical diagnostics, and agricultural science.


Address: Shirley, NY 11967, USA